1. OS01.7.A Detection of methylation-based prognostic signatures in liquid biopsy specimens from patients with meningiomas. (5th September 2022) Authors: Herrgott, G; Snyder, J; She, R; Malta, T; Sabedot, T; Lee, I; Pawloski, J; Asmaro, K; Zhang, J; Cannella, C; Nelson, K; Thomas, B; deCarvalho, A; Poisson, L; Chitale, D; Mukherjee, A; Mosella, M; Robin, A; Walbert, T; Rosenblum, M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS1.5 Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. (6th September 2019) Authors: Noushmehr, H; Sabedot, T; Malta, T; Nelson, K; Snyder, J; Wells, M; deCarvalho, A; Mukherjee, A; Chitale, D; Mosella, M; Asmaro, K; Robin, A; Rosenblum, M; Mikkelsen, T; Rock, J; Poisson, L; Walbert, T; Kalkanis, S; Castro, A Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS8.8 Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype. (6th September 2019) Authors: Malta, T; Sabedot, T; Lee, I; Wells, M; Castro, A; Noushmehr, H Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗